257 related articles for article (PubMed ID: 29254205)
1. An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer.
Lin M; Alnaggar M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
Oncotarget; 2017 Nov; 8(60):101795-101807. PubMed ID: 29254205
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
[TBL] [Abstract][Full Text] [Related]
3. Safety and Short-Term Efficacy of Irreversible Electroporation and Allogenic Natural Killer Cell Immunotherapy Combination in the Treatment of Patients with Unresectable Primary Liver Cancer.
Yang Y; Qin Z; Du D; Wu Y; Qiu S; Mu F; Xu K; Chen J
Cardiovasc Intervent Radiol; 2019 Jan; 42(1):48-59. PubMed ID: 30151798
[TBL] [Abstract][Full Text] [Related]
4. Allogenic Natural Killer Cell Immunotherapy Combined with Irreversible Electroporation for Stage IV Hepatocellular Carcinoma: Survival Outcome.
Alnaggar M; Lin M; Mesmar A; Liang S; Qaid A; Xu K; Chen J; Niu L; Yin Z
Cell Physiol Biochem; 2018; 48(5):1882-1893. PubMed ID: 30092590
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of irreversible electroporation ablation combined with natural killer cells in treating locally advanced pancreatic cancer.
Pan Q; Hu C; Fan Y; Wang Y; Li R; Hu X
J BUON; 2020; 25(3):1643-1649. PubMed ID: 32862617
[TBL] [Abstract][Full Text] [Related]
6. Short-term clinical efficacy of percutaneous irreversible electroporation combined with allogeneic natural killer cell for treating metastatic pancreatic cancer.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
Immunol Lett; 2017 Jun; 186():20-27. PubMed ID: 28392199
[TBL] [Abstract][Full Text] [Related]
7. Irreversible electroporation combined with chemotherapy for unresectable pancreatic carcinoma: a prospective cohort study.
Liu S; Qin Z; Xu J; Zeng J; Chen J; Niu L; Xu M
Onco Targets Ther; 2019; 12():1341-1350. PubMed ID: 30863100
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
He CB; Wang J; Mao YZ; Lao XM; Li SP
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
[No Abstract] [Full Text] [Related]
10. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
[TBL] [Abstract][Full Text] [Related]
11. Cryoablation combined with allogenic natural killer cell immunotherapy improves the curative effect in patients with advanced hepatocellular cancer.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
Oncotarget; 2017 Oct; 8(47):81967-81977. PubMed ID: 29137237
[TBL] [Abstract][Full Text] [Related]
12. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer.
Ma Y; Xing Y; Li H; Yuan T; Liang B; Li R; Li J; Li Z; Li S; Niu L
Front Immunol; 2023; 14():1193040. PubMed ID: 37691923
[TBL] [Abstract][Full Text] [Related]
13. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
14. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population.
Kwon JH; Chung MJ; Park JY; Lee HS; Hwang HK; Kang CM; Lee WJ; Park MS; Kim N; Bang S; Kim MD
Acta Radiol; 2021 Feb; 62(2):164-171. PubMed ID: 32295390
[TBL] [Abstract][Full Text] [Related]
15. Irreversible electroporation plus allogenic Vγ9Vδ2 T cells enhances antitumor effect for locally advanced pancreatic cancer patients.
Lin M; Zhang X; Liang S; Luo H; Alnaggar M; Liu A; Yin Z; Chen J; Niu L; Jiang Y
Signal Transduct Target Ther; 2020 Oct; 5(1):215. PubMed ID: 33093457
[TBL] [Abstract][Full Text] [Related]
16. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
[No Abstract] [Full Text] [Related]
17. Optimizing Patient Selection for Irreversible Electroporation of Locally Advanced Pancreatic Cancer: Analyses of Survival.
Woeste MR; Wilson KD; Kruse EJ; Weiss MJ; Christein JD; White RR; Martin RCG
Front Oncol; 2021; 11():817220. PubMed ID: 35096621
[TBL] [Abstract][Full Text] [Related]
18. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
Martin RC; McFarland K; Ellis S; Velanovich V
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
[TBL] [Abstract][Full Text] [Related]
19. Irreversible electroporation after induction chemotherapy versus chemotherapy alone for patients with locally advanced pancreatic cancer: A propensity score matching analysis.
He C; Wang J; Zhang Y; Lin X; Li S
Pancreatology; 2020 Apr; 20(3):477-484. PubMed ID: 32131993
[TBL] [Abstract][Full Text] [Related]
20. Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysis.
He C; Wang J; Sun S; Zhang Y; Lin X; Lao X; Cui B; Li S
BMC Cancer; 2019 Apr; 19(1):394. PubMed ID: 31029111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
